$TOI
Oncology Institute, Inc. Stock $toi

$toi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023037896 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$85.79M	$82.04M
YoY Change	20.11%	26.25%
Cost Of Revenue	$71.41M	$66.06M
YoY Change	27.98%	27.09%
Gross Profit	$14.38M	$15.98M
YoY Change	-8.0%	22.92%
Gross Profit Margin	16.76%	19.48%
Selling, General & Admin	$28.09M	$28.21M
YoY Change	-5.01%	-11.76%
% of Gross Profit	195.35%	176.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.573M	$914.0K
YoY Change	31.96%	132.57%
% of Gross Profit	10.94%	5.72%
Operating Expenses	$29.67M	$28.21M
YoY Change	-3.57%	-11.76%
Operating Profit	-$15.29M	-$13.93M
YoY Change	1.01%	-30.71%
Interest Expense	-$1.941M	-$1.760M
YoY Change	-20.78%	17.57%
% of Operating Profit
Other Income/Expense, Net	-$1.839M	-$3.359M
YoY Change	-111.38%	-119.31%
Pretax Income	-$19.07M	-$17.28M
YoY Change	67.65%	540.62%
Income Tax	-$314.0K	$135.0K
% Of Pretax Income
Net Earnings	-$15.29M	-$17.42M
YoY Change	74.96%	551.42%
Net Earnings / Revenue	-17.82%	-21.23%
Basic Earnings Per Share		-$0.19
Diluted Earnings Per Share	-$0.21	-$0.19
COMMON SHARES
Basic Shares Outstanding	73.75M shares	72.96M shares
Diluted Shares Outstanding		73.47M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.86M	$87.40M
YoY Change	12.26%	-3.51%
Cash & Equivalents	$33.49M	$27.54M
Short-Term Investments	$49.37M	$59.90M
Other Short-Term Assets	$4.049M	$4.200M
YoY Change	-41.47%	-45.13%
Inventory	$13.68M	$12.17M
Prepaid Expenses		$4.190M
Receivables	$42.36M	$48.44M
Other Receivables	$551.0K	$464.0K
Total Short-Term Assets	$143.5M	$152.7M
YoY Change	10.03%	6.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.05M	$10.79M
YoY Change	368.61%	53.97%
Goodwill	$7.230M	$7.230M
YoY Change	-66.24%	-76.69%
Intangibles	$17.90M	$18.56M
YoY Change	-0.3%	-0.56%
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Assets	$561.0K	$560.0K
YoY Change	17.61%	21.48%
Total Long-Term Assets	$65.75M	$65.67M
YoY Change	-49.91%	-53.15%
TOTAL ASSETS
Total Short-Term Assets	$143.5M	$152.7M
Total Long-Term Assets	$65.75M	$65.67M
Total Assets	$209.2M	$218.4M
YoY Change	-20.04%	-23.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.43M	$13.33M
YoY Change	53.96%	19.52%
Accrued Expenses	$16.76M	$12.72M
YoY Change	14.82%	-21.21%
Deferred Revenue	$545.0K	$545.0K
YoY Change	-52.15%	-57.36%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$34.79M	$32.39M
YoY Change	17.05%	-1.41%
LONG-TERM LIABILITIES
Long-Term Debt	$86.83M	$85.25M
YoY Change	7.7%	7.82%
Other Long-Term Liabilities	$30.57M	$459.0K
YoY Change	3421.77%	-52.68%
Total Long-Term Liabilities	$117.4M	$85.71M
YoY Change	44.06%	7.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.79M	$32.39M
Total Long-Term Liabilities	$117.4M	$85.71M
Total Liabilities	$152.2M	$146.5M
YoY Change	9.91%	-6.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$146.2M	-$127.4M
YoY Change	131.68%	144.64%
Common Stock	$8.000K	$8.000K
YoY Change	14.29%	14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$57.03M	$71.85M
YoY Change
Total Liabilities & Shareholders Equity	$209.2M	$218.4M
YoY Change	-20.04%	-23.06%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$15.29M	-$17.42M
YoY Change	74.96%	551.42%
Depreciation, Depletion And Amortization	$1.573M	$914.0K
YoY Change	31.96%	132.57%
Cash From Operating Activities	-$3.895M	-$8.310M
YoY Change	-72.17%	-59.26%
INVESTING ACTIVITIES
Capital Expenditures	$857.0K	$930.0K
YoY Change	-57.04%	-178.15%
Acquisitions
YoY Change
Other Investing Activities	$12.49M	$8.640M
YoY Change	-140.84%	-109.98%
Cash From Investing Activities	$11.63M	$7.710M
YoY Change	-135.71%	-108.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.777M	-760.0K
YoY Change	109.8%	-100.72%
NET CHANGE
Cash From Operating Activities	-3.895M	-8.310M
Cash From Investing Activities	11.63M	7.710M
Cash From Financing Activities	-1.777M	-760.0K
Net Change In Cash	5.958M	-1.360M
YoY Change	-112.57%	-51.13%
FREE CASH FLOW
Cash From Operating Activities	-$3.895M	-$8.310M
Capital Expenditures	$857.0K	$930.0K
Free Cash Flow	-$4.752M	-$9.240M
YoY Change	-70.29%	-51.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	73748979	shares
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14010000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39816000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	617000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9261000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4190000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6918000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	130418000	usd
CY2023Q3	us-gaap	Long Term Investments LongTermInvestments	0	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	58354000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10787000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8547000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28533000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	24494000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18561000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17957000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7230000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	21418000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	560000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	477000	usd
CY2023Q3	us-gaap	Assets Assets	218353000	usd
CY2022Q4	us-gaap	Assets Assets	261665000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13333000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9372000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6079000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5498000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	255000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	255000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14595000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	32390000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29720000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26014000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22060000	usd
CY2023Q3	toi	Derivative Warrant Liabilities Noncurrent DerivativeWarrantLiabilitiesNoncurrent	292000	usd
CY2022Q4	toi	Derivative Warrant Liabilities Noncurrent DerivativeWarrantLiabilitiesNoncurrent	350000	usd
CY2023Q3	toi	Derivative Earnout Liabilities DerivativeEarnoutLiabilities	11000	usd
CY2022Q4	toi	Derivative Earnout Liabilities DerivativeEarnoutLiabilities	803000	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1926000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3960000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	85254000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	868000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	158000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	108000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	146504000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	138490000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82035000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28205000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31963000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1698000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1134000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	85074000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13925000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20097000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1497000	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	940000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-140000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3359000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17399000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17284000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2698000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	135000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17419000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2674000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73469101	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72184366	shares
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4657000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8553000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	131998000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5453000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13358000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18561000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	59796000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001799191
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90703
	dei	City Area Code CityAreaCode	(562)
	dei	Local Phone Number LocalPhoneNumber	735-3226
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12723000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	80621000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	459000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75461901	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73728127	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73265621	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73265621	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	165045	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	165045	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	165045	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	165045	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	200256000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	186250000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1733774	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2023Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	1019000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127396000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63082000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	71849000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	123175000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	218353000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	261665000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64977000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238451000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85761000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	90117000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4296000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3219000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	95960000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	300181000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	237931000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-61730000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56872000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2695000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8017000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1632000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	0	usd
	us-gaap	Interest Income Other InterestIncomeOther	3181000	usd
	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	203000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	159000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-58000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-445000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-23000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3581000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-792000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-53821000	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1284000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	15510000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2034000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	15510000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	183000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-354000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-172000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2306000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	68155000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64036000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11283000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	278000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-64314000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11159000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73679454	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72807277	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73469101	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79581304	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73679454	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75300018	shares
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5229000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	98406000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-16897000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4107000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	894000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	84722000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17419000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	125000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	71849000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	104159000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	19286000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	337000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	9000000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	413000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6514000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	123983000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2674000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	79000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6546000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	127934000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-64314000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11159000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4296000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3219000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4633000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	892000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	13731000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	21613000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-58000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-445000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-792000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-53821000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2034000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	15510000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	44000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-62000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	712000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	29000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	50000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	183000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	183000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	31000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	402000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8657000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15215000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2913000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2584000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-153000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-678000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2728000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3545000	usd
	toi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-4448000	usd
	toi	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-3720000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	83000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	141000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	579000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2894000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	255000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3961000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4404000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3909000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2998000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-394000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1073000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32422000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-47759000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3706000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3534000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4300000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8107000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	9683000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	87402000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	68702000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	51013000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99043000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	110000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3663000	usd
	toi	Payments For Financing Of Insurance Payments PaymentsForFinancingOfInsurancePayments	3010000	usd
	toi	Payments For Financing Of Insurance Payments PaymentsForFinancingOfInsurancePayments	3739000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	959000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	509000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	91000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	39000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1019000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	416000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	413000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5066000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	93053000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13525000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-53749000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14010000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115174000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27535000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61425000	usd
	toi	Interest And Principal Forgiven From Paycheck Protection Program Loan Cares Act InterestAndPrincipalForgivenFromPaycheckProtectionProgramLoanCaresAct	0	usd
	toi	Interest And Principal Forgiven From Paycheck Protection Program Loan Cares Act InterestAndPrincipalForgivenFromPaycheckProtectionProgramLoanCaresAct	183000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	226000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26000	usd
	us-gaap	Interest Paid Net InterestPaidNet	3383000	usd
	us-gaap	Interest Paid Net InterestPaidNet	184000	usd
	toi	Discount On Convertible Debt DiscountOnConvertibleDebt	0	usd
	toi	Discount On Convertible Debt DiscountOnConvertibleDebt	28160000	usd
	toi	Deferred Consideration As Part Of Practice Acquisitions DeferredConsiderationAsPartOfPracticeAcquisitions	1813000	usd
	toi	Deferred Consideration As Part Of Practice Acquisitions DeferredConsiderationAsPartOfPracticeAcquisitions	0	usd
	toi	Number Of Oncologists And Mid Level Professionals Within Three States Minimum NumberOfOncologistsAndMidLevelProfessionalsWithinThreeStatesMinimum	112	oncologist
	toi	Number Of Clinic Locations NumberOfClinicLocations	70	clinic_location
CY2023Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	5	state
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates under different assumptions or conditions. Significant items subject to such estimates and assumptions include judgements related to revenue recognition, estimated accounts receivable and the allowance for credit losses, useful lives and recoverability of long-lived and intangible assets, recoverability of goodwill, fair values of acquired identifiable assets and assumed liabilities in business combinations, fair value of intangible assets and goodwill, fair value of share-based compensation, fair value of liability classified instruments, and judgements related to deferred income taxes.</span></div>
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16867000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48442000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39816000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	31000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	42000	usd
CY2023Q3	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	0	usd
	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	11000	usd
CY2022Q2	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	-28000	usd
	toi	Accounts Receivable Allowance For Credit Loss Recovery Reversal AccountsReceivableAllowanceForCreditLossRecoveryReversal	-110000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	115000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	292000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82035000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64977000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	238451000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	181059000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	545000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1139000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	12174000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	9261000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	60211000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	334000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	59877000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121101000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	384000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	120723000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	59877000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	usd
CY2023Q3	toi	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	59877000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	72892000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	47831000	usd
CY2022Q4	toi	Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	120723000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-157000	usd
	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-44000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	6	security
CY2023Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	270000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	274000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5440000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3506000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10787000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8547000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	914000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	393000	usd
	us-gaap	Depreciation Depreciation	2056000	usd
	us-gaap	Depreciation Depreciation	1066000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5137000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5310000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	545000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1139000	usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	0	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3010000	usd
CY2023Q3	toi	Business Combination Consideration Transferred Other Current BusinessCombinationConsiderationTransferredOtherCurrent	3318000	usd
CY2022Q4	toi	Business Combination Consideration Transferred Other Current BusinessCombinationConsiderationTransferredOtherCurrent	802000	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1100000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1100000	usd
CY2023Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	2623000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3234000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12723000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14595000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1971000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1576000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5572000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3992000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	10000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	14000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	48000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	41000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	2000	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	9000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	94000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	37000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	306000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	308000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	263000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	891000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	690000	usd
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M1D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0634
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0515
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0645
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0595
	us-gaap	Operating Lease Payments OperatingLeasePayments	5448000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3814000	usd
	toi	Repayments For Finance Lease RepaymentsForFinanceLease	91000	usd
	toi	Repayments For Finance Lease RepaymentsForFinanceLease	39000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9011000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	29468000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	203000	usd
CY2023Q3	toi	Lessee Operating Lease Number Of Clinic Lease Term Extensions LesseeOperatingLeaseNumberOfClinicLeaseTermExtensions	3	clinic_location
CY2023Q3	toi	Operating Lease Modification Liability Increase Decrease OperatingLeaseModificationLiabilityIncreaseDecrease	1274000	usd
CY2023Q3	toi	Operating Lease Modification Liability Increase Decrease Lease Incentives OperatingLeaseModificationLiabilityIncreaseDecreaseLeaseIncentives	1274000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2034000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	12000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7730000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	47000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7349000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	42000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6731000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	39000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5439000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	29000	usd
CY2023Q3	toi	Lessee Operating Lease Liability To Be Paid Thereafter LesseeOperatingLeaseLiabilityToBePaidThereafter	9215000	usd
CY2023Q3	toi	Finance Lease Liability To Be Paid Thereafter FinanceLeaseLiabilityToBePaidThereafter	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	38498000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	169000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6405000	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	20000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	32093000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	149000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6079000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	39000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26014000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	110000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	32093000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	149000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y5M4D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M13D
	toi	Lessee Operating Lease Number Of Clinics With Expanded Lease Space LesseeOperatingLeaseNumberOfClinicsWithExpandedLeaseSpace	1	clinic_location
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	125000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000	shares
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	894000	usd
CY2022Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	20000000	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1500000	shares
	toi	Lessee Operating Lease Number Of Clinic Lease Term Extensions LesseeOperatingLeaseNumberOfClinicLeaseTermExtensions	5	clinic_location
	toi	Operating Lease Modification Liability Increase Decrease OperatingLeaseModificationLiabilityIncreaseDecrease	3018000	usd
	toi	Operating Lease Modification Liability Increase Decrease Lease Incentives OperatingLeaseModificationLiabilityIncreaseDecreaseLeaseIncentives	-3021000	usd
	toi	Operating Lease Modification Increase Decrease In Rent Expenses OperatingLeaseModificationIncreaseDecreaseInRentExpenses	3000	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	110000000	usd
CY2022Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	110000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	135000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	278000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	124000	usd
CY2023Q3	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	159000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0043
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0110
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73728127	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	73265621	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	73265621	shares
	toi	Common Stock Votes Per Share CommonStockVotesPerShare	1	vote
	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	163510	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	165045	shares
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	100	shares
CY2023Q3	toi	Preferred Stock Maximum Percent Of Common Stock Allowed PreferredStockMaximumPercentOfCommonStockAllowed	0.0499
CY2021Q4	toi	Class Of Warrant Or Right Threshold Number Of Business Days Before Sending Notice Of Redemption To Warrant Holders ClassOfWarrantOrRightThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders	3	d
CY2023Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	9000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8049474	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1948354	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.48
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	14616	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.86
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1050646	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.31
	toi	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriod	103184	shares
	toi	Share Based Compensation Arrangements By Share Based Payment Award Options Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExercisePrice	1.32
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8829382	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M2D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4110000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3915306	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.32
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M28D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1925000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6921180	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.89
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1563633	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.14
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	460385	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.91
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	833687	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.17
	toi	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriod	1876	shares
	toi	Share Based Compensation Arrangements By Share Based Payment Award Options Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExercisePrice	1.13
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7188865	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.10
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M3D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21744000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2762097	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.87
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M26D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10391000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1616000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6976000	usd
CY2022	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	5	business_combination
CY2022	toi	Number Of Asset Acquired NumberOfAssetAcquired	1	asset_acquisition
CY2023Q3	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	0	business_combination
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	1	business_combination
CY2023Q3	toi	Number Of Asset Acquired NumberOfAssetAcquired	0	asset_acquisition
	toi	Number Of Asset Acquired NumberOfAssetAcquired	0	asset_acquisition
CY2023Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	41000	usd
CY2022Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	166000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	112000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	700000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	31919000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	29075000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11118000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17957000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	770000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3078000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3075000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3050000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2923000	usd
CY2023Q3	toi	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	5665000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18561000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	784000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	741000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2240000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2153000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7230000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	21418000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	21418000	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	26626000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2679000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4736000	usd
CY2023Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	16867000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	9944000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	7230000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	21418000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17419000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2674000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-64314000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11159000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	64000	usd
CY2023Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-17419000	usd
CY2022Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-2674000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-64314000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	11095000	usd
CY2023Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-3148000	usd
CY2022Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-499000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	-11723000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	2290000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14271000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2175000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-52591000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8805000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73469101	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72184366	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73679454	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72807277	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-17419000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2674000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-64314000	usd
	us-gaap	Net Income Loss NetIncomeLoss	11159000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	64000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-13970000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-13970000	usd
CY2023Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-17419000	usd
CY2022Q3	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-16644000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-64314000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-2875000	usd
CY2023Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-3148000	usd
CY2022Q3	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-2867000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-11723000	usd
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	-515000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-14271000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13777000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73679454	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72807277	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7396938	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7396938	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73469101	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79581304	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13925000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20097000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-61730000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-56872000	usd
CY2023Q3	us-gaap	Assets Assets	218353000	usd
CY2022Q4	us-gaap	Assets Assets	261665000	usd
CY2023Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	199000	usd
CY2022Q3	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	126000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	417000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	9072000	usd

Files In Submission

Name	View Source	Status
toi-20230930_cal.xml	Edgar Link	unprocessable
0001628280-23-037896-index-headers.html	Edgar Link	pending
0001628280-23-037896-index.html	Edgar Link	pending
0001628280-23-037896.txt	Edgar Link	pending
0001628280-23-037896-xbrl.zip	Edgar Link	pending
ex102executiveemploymentag.htm	Edgar Link	pending
ex311-certificationrule13a.htm	Edgar Link	pending
ex312-certificationrule13a.htm	Edgar Link	pending
ex321-ceocertificationsect.htm	Edgar Link	pending
ex322-cfocertificationsect.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
toi-20230930.htm	Edgar Link	pending
toi-20230930.xsd	Edgar Link	pending
toi-20230930_def.xml	Edgar Link	unprocessable
toi-20230930_lab.xml	Edgar Link	unprocessable
toi-20230930_pre.xml	Edgar Link	unprocessable
toi-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TOI
Oncology Institute, Inc. Stock $toi

2023 Q4 Form 10-Q Financial Statement

#000162828023037896 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOI Oncology Institute, Inc. Stock $toi

2023 Q4 Form 10-Q Financial Statement

#000162828023037896 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOI
Oncology Institute, Inc. Stock $toi